Grab your favorite mug and join your colleagues and TAHP staff for a cup of joe. Laurie will provide an overview of the policy changes related to COVID-19, updates on legislative implementation and share what we are hearing related to staffing at the agency.
Molluscum contagiosum is a highly contagious viral skin infection found mainly in children that affects roughly 6 million people per year in the US. This presentation will include information on symptoms, incidence and prevalence, how the disease is spread, available (non-FDA approved) treatments, and how it affects patients’ lives.
Attendees will learn about current pharmacy trends, drug pipeline and recent developments impacting Medical and Pharmacy Specialty spend.
Participants will have the opportunity to hear from Dr. McClellan, one of Governor Abbott’s medical advisers on the StrikeForce to Open Texas and the former administrator of CMS and commissioner of the U.S. FDA, on the current state of COVID-19 and Texas’ response.
Grab your favorite mug and join Dr. John Zerwas for an update on the Governor’s Strike Force and its COVID-19 response.
This presentation will inform and educate on how ALS affects a person and their family from diagnosis to end-of-life. We will explore the QoL factors and external pressures that manifest as a result of disease progression. A diagnosis of ALS is ominous, but there is hope.
The therapeutic community provides an additional alternative for those seeking recovery who have found traditional short-term residential programs and/or outpatient services unsuccessful. This presentation will provide processes that enhance therapeutic services through a holistic approach, including clinical support, education initiatives, medical and dental support and vocational skills training in addition to other services while in treatment.
This discussion will provide an overview of the value and important considerations in the management of the NEMT benefit. In addition to an “NEMT 101,” we will provide insight on NEMT as a member-facing experience and differentiator, the Non-Emergent Transportation vendor market, and approaches to contracting and managing vendor performance. Following the discussion, participants will have a greater understanding of their role in providing a high-quality, cost-controlled transportation experience to their members.